⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5075375 | 0.86 | — | — | |
| SCHEMBL5007817 | 0.78 | — | — | |
| SCHEMBL11393742 | 0.78 | — | — | |
| SCHEMBL1205184 | 0.75 | ALDH1A1 (0.32) | — | |
| SCHEMBL7503979 | 0.71 | — | — | |
| SCHEMBL9024159 | 0.71 | POLB (0.31) | — | |
| SCHEMBL1191368 | 0.69 | — | — | |
| SCHEMBL2201788 | 0.69 | — | — | |
| SCHEMBL7780167 | 0.69 | — | — | |
| SCHEMBL18042438 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8563729-B2 | Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators | MERCK PATENT GMBH (DE) | 2013-10-22 | — | — | US | disclosed |
| EP-1973886-B1 | PROKINETICIN 1 RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2013-02-27 | — | — | EP | disclosed |
| US-20110034505-A1 | THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS | MERCK PATENT GESELLSCHAFT (DE) | 2011-02-10 | — | — | US | disclosed |
| US-7504517-B2 | Kv1.5 potassium channel inhibitors | WYETH (US) | 2009-03-17 | — | — | US | disclosed |
| US-20070299120-A1 | KV1.5 POTASSIUM CHANNEL INHIBITORS | WYETH (US) | 2007-12-27 | — | — | US | disclosed |
| US-6476061-B1 | Fungicides containing pyrrolidones as their active agents | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-05 | — | — | US | disclosed |
| US-6294539-B1 | METALLOCENE ENZYME INHIBITORS AS ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS AND ANTIARTHRITIC AGENTS | ADVANCED SYNTECH, LLC | 2001-09-25 | — | — | US | disclosed |